Ajanta Pharma Limited
NSE: AJANTPHARM | Information Technology
Market Fundamentals
Stock Intelligence & News
Ajanta Pharma Limited
Ajanta Pharma Limited has informed the Exchange about (Revised) Participation in Investor Conference |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Rajesh Palviya of Axis Sec suggests Ajanta Pharma, Tata Communications, NMDC shares to buy today - 15 May
The stock market saw gains on May 15, with Sensex rising 451.46 points and Nifty 50 up 143.25 points, led by IT stocks. Oil companies faced declines after fuel price increases, while the market remains volatile within a range of 24,500 to 23,200.
Read Full Analysis →Vodafone Idea and 4 other midcap stocks hit 52-week highs, rally up to 40% in a month
Benchmark indices ended marginally higher as five BSE 150 Midcap stocks touched fresh 52-week highs, reflecting strong investor sentiment and bullish momentum. Vodafone Idea, SAIL, MCX, Laurus Labs and Ajanta Pharma recorded notable monthly gains, signalling sustained buying interest despite subdued broader market performance overall.
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Raja Venkatraman, MarketSmith recommend five stocks for 7 May
Indian stock markets surged on May 6, with Sensex up 941 points and Nifty 50 gaining 298 points. The rally was broad-based, boosted by reports of easing US-Iran tensions. Analysts recommend stocks like Godrej Industries and Ajanta Pharma for potential gains in the current market.
Read Full Analysis →Ajanta Pharma Limited
Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Ajanta Pharma Limited
Ajanta Pharma Limited has informed the Exchange about Link of Recording |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Ajanta Pharma Limited
Ajanta Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. |SUBJECT: Outcome of Board Meeting
Read Full Analysis →Ajanta Pharma Limited
Ajanta Pharma Limited has informed the Exchange about General Updates |SUBJECT: General Updates
Read Full Analysis →Ajanta Pharma Limited
Board Meeting Intimation |Meeting Date: 05-May-2026
Read Full Analysis →Ajanta Pharma Limited
Financial Results |Meeting Date: 05-May-2026
Read Full Analysis →Get instant alerts when AJANTPHARM breaks news
Join investors who track Ajanta Pharma Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for AJANTPHARM?
AJANTPHARM is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Ajanta Pharma Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding AJANTPHARM to your custom watchlist.